Clinical publications 

The scientific publications provided are for informational purposes only and are available according to the author’s agreement to release them. For any questions about these and their use, please email: medicalaffairs@nektar.com.

Charych D, et al. PLoS One 2017;12:e0179431.

Charych D, et al. Clin Cancer Res 20126;22:680-90

Bentebibel SE, et al. Cancer Discov 2019;9:711–21.

Diab A, et al. Cancer Discov 2020;10:1158–73.

Diab A, et al. Oral presentation at SITC 2020:Abstract 420.

Poster P-075: “Benchmarking efficacy outcomes for patients with relapsed/refractory advanced melanoma previously treated with immunotherapy: Utility of a systematic pooled clinical analysis”, M. Mushin et al.

TiP Poster P-047: “PIVOT-12: a Phase 3 randomized study of adjuvant bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) versus NIVO in completely resected cutaneous melanoma at high risk for recurrence”, A. Eggermont, et al.

Poster P-042: “Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study”, A. Diab, et al.